Despite the advances in electronic content management over the
past decade, many of the biggest global life sciences companies still
manage their local translations in a highly fragmented way. Not
only does it lead to a rise in costs, but it also comes with risks to
safety and slows down product speed-to-market. However, there
is a smarter approach to take, as outlined by Jason Arnsparger of
AMPLEXOR.